Noah Goodman
Chief Business Officer at Kymera Therapeutics, Inc. (KYMR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,38947,179 held (−7%) | $114.29 | $387K | -1.7% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,50052,695 held (−5%) | $109.00 | $272K | +3.1% |
| Jun 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,50050,195 held (−5%) | $119.00 | $298K | -5.5% |
| Jun 22SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,50050,195 held (−5%) | $99.00 | $248K | +13.5% |
| Apr 16SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,34750,195 held (−3%) | $90.00 | $121K | +24.9% |
| Apr 10SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,09458,712 held (−5%) | $86.62 | $268K | +29.8% |
| Apr 10SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,67056,042 held (−5%) | $87.11 | $233K | +29.0% |
| Apr 10SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,50053,542 held (−4%) | $89.00 | $222K | +26.3% |
| Apr 10SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 2,00051,542 held (−4%) | $87.35 | $175K | +28.7% |
- Sell
Chief Business Officer Noah Goodman sold $387K of KYMR at $114.29 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Business Officer Noah Goodman sold $272K of KYMR at $109.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Business Officer Noah Goodman sold $298K of KYMR at $119.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Business Officer Noah Goodman sold $248K of KYMR at $99.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Business Officer Noah Goodman sold $121K of KYMR at $90.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Business Officer Noah Goodman sold $268K of KYMR at $86.62 — pre-scheduled 10b5-1 plan sale.